NASH WITH FIBROSIS

Clinical trials for NASH WITH FIBROSIS explained in plain language.

Never miss a new study

Get alerted when new NASH WITH FIBROSIS trials appear

Sign up with your email to follow new studies for NASH WITH FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

Can a Two-Drug cocktail reverse liver scarring? early trial hints at possibility

Disease control Completed

This study tested whether a combination of two drugs, dasatinib and quercetin, can reduce liver scarring in people with non-alcoholic fatty liver disease (NAFLD) and fibrosis. Thirty adults with biopsy-confirmed liver scarring took either the drug combo or a placebo in cycles ove…

Matched conditions: NASH WITH FIBROSIS

Phase: PHASE1, PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC

NASH WITH FIBROSIS

Get alerted when new NASH WITH FIBROSIS trials appear

Can a Two-Drug cocktail reverse liver scarring? early trial hints at possibility